• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 14.02
  • VXN 16.95
  • VXO 14.44
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





Company Profile

Exact Sciences Corporation, a molecular diagnostics company, focuses on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Its non-invasive stool-based DNA (sDNA) screening technology includes proprietary and patented methods that isolate and analyze human deoxyribonucleic acid (DNA) present in stool to screen for the presence of colorectal pre-cancer and cancer. The company?s principal product includes ColoSure, a non-invasive stool-based DNA testing service for the detection of colorectal cancer in the average-risk population. Exact Sciences Corporation has a strategic alliance with LabCorp; a collaboration, license, and purchase agreement with Genzyme Corporation; and a licensing and research agreement with the MAYO Foundation for Medical Education and Research. The company was founded in 1995 and is headquartered in Madison, Wisconsin.

YES
     
EXAS (Exact Sciences Corp)
Last Trade 89.57 Date 1/24/2020
Change % -2.84 % Price Change -2.61
Open 92.42 52 Week High 123.99
High 92.7299 52 Week Low 75.35
Low 87.7 Type stock
Volume 1931875 Average Volume 2378179
Prev Close 92.18 Stock Exchange NASDAQ
Bid 89.26 Ask 89.57
Bid Size 1 Ask Size 2
1st Yr Estimated EPS Growth -0.6488 2nd Yr Estimated EPS Growth -2.2177
2 Years Forward Earning Yield 0.0089 2 Years Forward PE Ratio 111.9625
2 Years EV/Forward EBIT 77.5355 2 Years EV/Forward EBITDA 55.3123
Book Value per Share 5.0823 Book Value Yield 0.0567
Buy Back Yield CAPE Ratio
Cash Return -0.0178 Cash Flow per Share -0.6894
Cash Flow Yield -0.0077 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield -0.019 EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT 781.9822 EV / Forward EBITDA 150.8882
EV / Forward Revenue 9.0429 EV / Pre Tax Income
EV / Revenue 17.7478 EV / Total Asset 7.3008
Expected Dividend Growth Rate Free Cash Flow per Share -2.1386
Free Caash Flow Ratio Free Cash Flow Yield -0.0239
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield -0.0073 Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio 0.0
PB Ratio 17.623761 PB Ratio 10 Year Growth -0.024013
PB Ratio 3 Year Growth 13.004795 Cash Ratio 3 Year Average 1032.0207
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average PE Ratio 10 Year Growth
PE Ratio 10 Year High PE Ratio 10 Year Low
PE Ratio 1 Year Avg PE Ratio 1 Year High
PE Ratio 1 Year Low PE Ratio 3 Year Avg
PE Ratio 5 Year Avg PE Ratio 5 Year High
PE Ratio 5 Year Low Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg Price Change 1 Month 0.968534
Price to Cash Ratio 11.363263 Price / EBITDA
Price to Sales Ratio 15.71908 Price to Sales Ratio 10 Year Growth -0.05174
Price to Sales Ratio 3 Year Avg 23.671195 Price to Sales Ratio 5 Year Avg
Sale per Share 5.6982 Sales Yield 0.0636
Sustainable Growth Rate -0.2948 Tangible Book Value per Share 4.7809
Tangible Book Value per Share 3 year Avg 4.9303 Tangible Book Value per Share 5 year Avg 4.363
Total Asset per Share 11.9489 Total Yield
Working Capital per Share 5.7004 Working Capital per Share 3 Year Avg 6.3842
Working Capital per Share 5 Year Avg 5.1222 Beta 1.963913